China NMPA Inspection - Guangxi Fucodisai Regenerative Medicine Engineering Co., Ltd. - October 19, 2020
China NMPA unannounced inspection for Guangxi Fucodisai Regenerative Medicine Engineering Co., Ltd. published October 19, 2020. The Guangxi Zhuang Autonomous Region Drug Administration conducted unannounced inspections of cosmetics manufacturers in October 2020, adhering to the
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Guangxi Fucodisai Regenerative Medicine Engineering Co., Ltd. published October 19, 2020. The Guangxi Zhuang Autonomous Region Drug Administration conducted unannounced inspections of cosmetics manufacturers in October 2020, adhering to the
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
cosmetics
ID: e51a202e-a79e-4657-b6d0-8da818a1d0ad
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox